TABLE 5.
Pairwise comparisons of ROC curves.
| Comparison | Difference between areas | 95% CI | P-value |
| AA vs. EPA | 0.053 | –0.055–0.161 | 0.335 |
| AA vs. DHA | 0.120 | 0.005–0.235 | 0.041 |
| EPA vs. DHA | 0.067 | 0.018–0.115 | 0.007 |
| EPA/AA vs. AA | 0.070 | 0.006–0.134 | 0.031 |
| EPA/AA vs. EPA | 0.123 | 0.060–0.187 | 0.0001 |
| DHA/AA vs. AA | 0.060 | –0.019–0.139 | 0.137 |
| DHA/AA vs. DHA | 0.180 | 0.120–0.239 | < 0.0001 |
| EPA/AA vs. DHA/AA | 0.010 | –0.043 to 0.064 | 0.709 |
| DHA/AA vs. EPA | 0.113 | 0.046 to 0.181 | 0.001 |
| EPA/AA vs. DHA | 0.190 | 0.105 to 0.275 | < 0.0001 |
AA, arachidonic acid; CAD, coronary artery disease; DHA, docosahexaenoic acid; DHA/AA, ratio of DHA and AA; EPA, eicosapentaenoic acid; EPA/AA, ratio of EPA and AA; ROC, receiver operating characteristic.